92 related articles for article (PubMed ID: 26676943)
1. Obese type 2 diabetes mellitus patients have higher serum vaspin concentrations.
Dai R; Dong Z; Qian Y; Han Y
J Diabetes; 2016 May; 8(3):445-7. PubMed ID: 26676943
[No Abstract] [Full Text] [Related]
2. Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes.
Yang L; Chen SJ; Yuan GY; Wang D; Chen JJ
Genet Mol Res; 2015 Sep; 14(3):11356-61. PubMed ID: 26436376
[TBL] [Abstract][Full Text] [Related]
3. Serum Vaspin Concentration in Elderly Type 2 Diabetes Mellitus Patients with Differing Body Mass Index: A Cross-Sectional Study.
Yang W; Li Y; Tian T; Wang L
Biomed Res Int; 2017; 2017():4875026. PubMed ID: 28553648
[No Abstract] [Full Text] [Related]
4. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women.
Saboori S; Hosseinzadeh-Attar MJ; Yousefi Rad E; Hosseini M; Mirzaei K; Ahmadivand Z
Diabetes Metab Syndr; 2015; 9(4):320-3. PubMed ID: 25470626
[TBL] [Abstract][Full Text] [Related]
5. Serum vaspin concentrations in human obesity and type 2 diabetes.
Youn BS; Klöting N; Kratzsch J; Lee N; Park JW; Song ES; Ruschke K; Oberbach A; Fasshauer M; Stumvoll M; Blüher M
Diabetes; 2008 Feb; 57(2):372-7. PubMed ID: 17991760
[TBL] [Abstract][Full Text] [Related]
6. Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications.
Yang W; Li Y; Tian T; Wang L; Lee P; Hua Q
BMC Endocr Disord; 2017 Oct; 17(1):67. PubMed ID: 29065866
[TBL] [Abstract][Full Text] [Related]
7. Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus.
El-Lebedy DH; Ibrahim AA; Ashmawy IO
Diabetes Metab Syndr; 2018 Sep; 12(5):643-648. PubMed ID: 29673927
[TBL] [Abstract][Full Text] [Related]
8. Vaspin serum concentration in patients with type 2 diabetes and carotid plaque.
Li Z; Ma C; Li L; Pan X; Chen L
J Int Med Res; 2012; 40(5):1670-6. PubMed ID: 23206449
[TBL] [Abstract][Full Text] [Related]
9. Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity.
Li K; Li L; Yang M; Liu H; Liu D; Yang H; Boden G; Yang G
Eur J Endocrinol; 2011 Jun; 164(6):905-10. PubMed ID: 21471167
[TBL] [Abstract][Full Text] [Related]
10. Vaspin serum concentrations in patients with carotid stenosis.
Aust G; Richter O; Rohm S; Kerner C; Hauss J; Klöting N; Ruschke K; Kovacs P; Youn BS; Blüher M
Atherosclerosis; 2009 May; 204(1):262-6. PubMed ID: 18848328
[TBL] [Abstract][Full Text] [Related]
11. Association of serum vaspin and adiponectin levels with renal function in patients with or without type 2 diabetes mellitus.
Yan M; Su B; Peng W; Li L; Li H; Zhuang J; Lu Y; Jian W; Wei Y; Li W; Qu S; Xu Y
J Diabetes Res; 2014; 2014():868732. PubMed ID: 25133192
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the vaspin gene affects circulating serum vaspin concentrations.
Breitfeld J; Tönjes A; Böttcher Y; Schleinitz D; Wiele N; Marzi C; Brockhaus C; Rathmann W; Huth C; Grallert H; Illig T; Blüher M; Kovacs P; Stumvoll M
Int J Obes (Lond); 2013 Jun; 37(6):861-6. PubMed ID: 22907691
[TBL] [Abstract][Full Text] [Related]
13. Association of vaspin gene expression and its serum level on the risk of ischemic stroke in type 2 diabetic Egyptian patients: Prospective case-control study.
Rashad NM; Ahmed HS; Ashour WMR; Yousef MS
Biotechnol Appl Biochem; 2020 Nov; 67(6):912-919. PubMed ID: 31706261
[TBL] [Abstract][Full Text] [Related]
14. Gender-dependent effects of metformin on vaspin and adiponectin in type 2 diabetes patients: a randomized clinical trial.
Esteghamati A; Mousavizadeh M; Noshad S; Zandieh A; Zarei H; Nakhjavani M
Horm Metab Res; 2013 Apr; 45(4):319-25. PubMed ID: 23225237
[TBL] [Abstract][Full Text] [Related]
15. Vaspin in obesity and diabetes: pathophysiological and clinical significance.
Blüher M
Endocrine; 2012 Apr; 41(2):176-82. PubMed ID: 22139797
[TBL] [Abstract][Full Text] [Related]
16. Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: a meta-analysis.
Feng R; Li Y; Wang C; Luo C; Liu L; Chuo F; Li Q; Sun C
Diabetes Res Clin Pract; 2014 Oct; 106(1):88-94. PubMed ID: 25151227
[TBL] [Abstract][Full Text] [Related]
17. Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus.
Akbarzadeh S; Nabipour I; Jafari SM; Movahed A; Motamed N; Assadi M; Hajian N
Diabetes Res Clin Pract; 2012 Jan; 95(1):132-8. PubMed ID: 22024288
[TBL] [Abstract][Full Text] [Related]
18. Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia.
Stepan H; Kralisch S; Klostermann K; Schrey S; Reisenbüchler C; Verlohren M; Verlohren HJ; Drynda K; Blüher M; Stumvoll M; Kratzsch J; Kovacs P; Fasshauer M
Metabolism; 2010 Jul; 59(7):1054-6. PubMed ID: 20045145
[TBL] [Abstract][Full Text] [Related]
19. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.
Karbek B; Bozkurt NC; Topaloglu O; Aslan MS; Gungunes A; Cakal E; Delibasi T
Minerva Endocrinol; 2014 Jun; 39(2):99-105. PubMed ID: 24736484
[TBL] [Abstract][Full Text] [Related]
20. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance.
Chang HM; Lee HJ; Park HS; Kang JH; Kim KS; Song YS; Jang YJ
Obesity (Silver Spring); 2010 Nov; 18(11):2105-10. PubMed ID: 20339362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
